Skip to main content
MN

Dr. Michael C. Nemunaitis

MD·Medical Oncology

6780 MAYFIELD RD, Mayfield Heights, OH 44124

Medicare Accepted
Telehealth Available
25+ Years Experience

Contact Dr. Nemunaitis

Get Directions

6780 MAYFIELD RD, Mayfield Heights, OH 44124

For Providers

Manage This Profile

Specialty

Medical Oncologists

Coverage

Medicare + 6 Networks

Telehealth

Available

About Dr. Michael C. Nemunaitis

Background and practice information

Dr. Michael C. Nemunaitis is a medical oncologist with over 25 years of clinical experience serving patients in the Mayfield Heights, OH area. He completed his medical training at Medical College Of Ohio and has been in practice since 2001. He currently practices at Cleveland Clinic.

Dr. Michael C. Nemunaitis's clinical practice focuses on treating patients with breast cancer, inflammation, autoimmune conditions, and allergic reactions, prostate cancer, and related conditions.

Dr. Michael C. Nemunaitis is in-network with 6 insurance providers, including Aetna, Cigna, Medicare, and 3 more. Patients are encouraged to verify coverage with his office before scheduling an appointment.

At a Glance

GenderMale
Experience25+ years
MedicareAccepted
TelehealthAvailable

Education

Medical SchoolMedical College Of Ohio
Graduated2001

Are you Dr. Nemunaitis?

Update your photo, bio, contact info, and accepting-new-patients status. Earn the “Verified” badge.

Claim this profile

Practice Locations

4 locations

Cleveland Clinic

Primary

6780 Mayfield Rd

Mayfield Heights, OH 44124

Cleveland Clinic

8701 Darrow Rd

Twinsburg, OH 44087

(330) 888-4000

View 2 more locations

Cleveland Clinic

8950 Euclid Ave

Cleveland, OH 44195

(216) 444-8950

Cleveland Clinic

9500 Euclid Ave

Cleveland, OH 44195

Treatment & Experience

Clinical practice and procedure experience for Dr. Michael C. Nemunaitis

Services & Procedures

Dr. Michael C. Nemunaitis's clinical practice encompasses office visits, hospital care.

Office Visits

795 services

Dr. Michael C. Nemunaitis provides patient consultations ranging from routine follow-ups to comprehensive evaluations, including follow-up visit and new patient visit and phone consultation. Medicare patients typically pay significantly less than the standard charge for these services, with Medicare-approved rates averaging 88% below the billed amount.

Hospital Care

91 services

Dr. Michael C. Nemunaitis manages inpatient hospital care including admissions, daily rounds, critical care, and discharge coordination, including hospital admission and daily hospital rounds. Medicare patients typically pay significantly less than the standard charge for these services, with Medicare-approved rates averaging 91% below the billed amount.

Treatment Approach

Dr. Michael C. Nemunaitis's treatment approach includes prescribing Anastrozole, Prednisone, Letrozole for his patients. These medications are commonly used for treating breast cancer, inflammation, autoimmune conditions, and allergic reactions, prostate cancer. He prescribing profile reflects experience across a wide range of treatments, addressing multiple aspects of patient care within his specialty. Dr. Michael C. Nemunaitis has treated a significant number of Medicare patients, demonstrating an established practice in this area.

Anastrozole— for breast cancer
Prednisone— for inflammation, autoimmune conditions, and allergic reactions
Letrozole— for breast cancer
Abiraterone Acetate— for prostate cancer

Source: CMS Medicare Provider Utilization and Payment Data, 2023.

Insurance Networks

Accepted insurance plans and networks

Dr. Michael C. Nemunaitis accepts 41 plans from 6 insurers, including Cigna, UnitedHealthcare, Aetna.

Az Localflex Excl Ebh And Pathwell
Az Localflex Incl Ebh And Pathwell
Az Localflex Incl Ebh Excl Pathwell
Healthpartners Qualified Network
Localplus
Localplus Exclude Ebh With Pathwell
Localplus Sar
Localplus With Ebh Plus Pathwell
Mvp Mohawk Valley Physicians
National OapOAP
National PpoPPO
National Ppo Sar 1PPO
National Ppo Sar IiPPO
Oap Shared Admin RepricingOAP
Pathwell OapOAP
Pathwell PpoPPO
Priority Health Alliance

Source: CMS Transparency in Coverage filings (March 2026). Network participation may change — verify with the provider's office before scheduling.

Financial Transparency

Industry payment disclosures

Pharmaceutical and medical device companies disclosed $432 in payments to Dr. Michael C. Nemunaitis in 2024, primarily from AstraZeneca Pharmaceuticals LP for food and beverage. These disclosures are required by federal law under the Physician Payments Sunshine Act.

Top Paying Companies

AstraZeneca Pharmaceuticals LP$305
BeiGene USA, Inc.$127
Food and Beverage: $252Travel and Lodging: $180

Source: CMS Open Payments, 2024.

Patient Reviews

Reviews and ratings from patients

Loading reviews...

Is This Your Practice?

This profile appears in 6 insurance networks

  • Update your photo, bio, and contact info
  • Mark whether you’re accepting new patients
  • Earn the “Verified” badge

Starter $29 one-time. Professional from $59/mo unlocks review responses, office hours, photo gallery, and more.

About Medical Oncology

Specialty overview and common conditions

An oncologist is a medical doctor who specializes in diagnosing and treating cancer. Medical oncologists focus on treating cancer with medications including chemotherapy, immunotherapy, targeted therapy, and hormone therapy. They coordinate comprehensive cancer care, work closely with surgical and r...

Common conditions treated by medical oncology specialists:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
Learn more about medical oncology specialists

Frequently Asked Questions

Common questions about Michael C. Nemunaitis

Does Dr. Nemunaitis accept Medicare?

Yes, Dr. Nemunaitis accepts Medicare assignment. Patients with Medicare coverage can see Dr. Nemunaitis and typically pay less out of pocket when using a provider who accepts Medicare assignment.

What insurance does Dr. Nemunaitis accept?

Dr. Nemunaitis is in-network with 6 insurance providers, including Aetna, Cigna, Medicare, Oxford Health Plans (UHC), UMR, and 1 more. Insurance networks can change, so patients should verify their specific plan coverage directly with Dr. Nemunaitis's office before scheduling.

Does Dr. Nemunaitis offer telehealth or virtual appointments?

Yes, Dr. Nemunaitis offers telehealth services, allowing patients to have virtual consultations from the comfort of their home. Contact the office to schedule a telehealth appointment.

What conditions does Dr. Nemunaitis treat?

As a medical oncology specialist, Dr. Nemunaitis commonly treats conditions including breast cancer, lung cancer, colorectal cancer, prostate cancer, lymphoma (hodgkin and non-hodgkin), and other related health concerns. Contact the office to discuss your specific healthcare needs.

What medications does Dr. Nemunaitis commonly prescribe?

Based on Medicare prescribing data, Dr. Nemunaitis commonly prescribes medications including Anastrozole, Prednisone, Letrozole. The specific medications prescribed depend on each patient's individual diagnosis and health needs. Patients should discuss treatment options directly with Dr. Nemunaitis during their consultation.

Where did Dr. Nemunaitis go to medical school?

Dr. Nemunaitis completed medical training at Medical College Of Ohio and has been practicing since 2001, bringing over 25 years of clinical experience.

Where is Dr. Nemunaitis's office located?

Dr. Nemunaitis practices at 6780 MAYFIELD RD, Mayfield Heights, OH 44124 at CLEVELAND CLINIC. Contact the office for appointment scheduling.

How do I make an appointment with Dr. Nemunaitis?

To schedule an appointment with Dr. Nemunaitis, contact the office directly. New patients should have their insurance information and medical records ready when calling.

Data source: CMS National Provider Registry ·

Find Medical Oncologists in Nearby Cities

Browse medical oncologists providers in surrounding areas

Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice. Learn more about our editorial standards

Back to Search